Breaking Finance News

A statement released earlier today by Benchmark about LHC Group (NDAQ:LHCG) bumps the target price to $72.00

Boasting a price of $64.68, LHC Group (NDAQ:LHCG) traded -0.21% lower on the day. With the last stock price close up 7.85% from the two hundred day average, compared with the S&P 500 Index which has increased 0.03% over the date range. LHC Group has recorded a 50-day average of $66.35 and a two hundred day average of $62.07. Volume of trade was down over the average, with 109,706 shares of LHCG changing hands under the typical 157,186

Benchmark bumped up the target of LHC Group (NDAQ:LHCG) to $72.00 stating a potential upside of 0.11%.

On 05/09/2017, Oppenheimer released a statement for LHC Group (NDAQ:LHCG) bumped up the target price from $55.00 to $68.00 that suggested an upside of 0.12%.

Performance Chart


With a total market value of $0, LHC Group has price-earnings ratio of 29.62 with a one year low of $32.04 and a one year high of $73.85 .

Brief Synopsis About LHC Group (NDAQ:LHCG)

LHC Group, Inc. is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services. Through its home health services segment, the Company offers a range of services, including skilled nursing, medically oriented social services, and physical, occupational and speech therapy. Through its hospice services segment, the Company offers a range of services, including pain and symptom management, and emotional and spiritual support. Its community-based service operations offer a range of services to patients in their home or in a medical facility. The services range from assistance with grooming, medication reminders and meal preparation. It provides facility-based services principally through its LTACHs.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.